Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Summary

This study was conducted in subjects with grade IV astrocytic tumors (a type of cancer that can occur in the brain or spinal cord) in first or second relapse.

Timeline

Start

2010-04

Primary completion

2011-05

Completion

2013-10

Outcome

Outcome not reported

Stopped (Enrollment): “Enrollment in this study was terminated for business development reasons before completing one third of the expected subject population, no formal statistical testing was performed.”

Drugs

Indications